Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations

Tarun Dua; Corrado Barbui; Nicolas Clark; Alexandra Fleischmann; Vladimir Poznyak; Mark van Ommeren; M. Taghi Yasamy; José Luís Ayuso‐Mateos; Gretchen L. Birbeck; Colin Drummond; Melvyn Freeman; Pantéleimon Giannakopoulos; Itzhak Levav; Isidore Obot; Olayinka Omigbodun; Vikram Patel; Michael R. Phillips; Martin Prince; Afarin Rahimi‐Movaghar; Atıf Rahman; Josemir W. Sander; John B. Saunders; Chiara Servili; R. Thara; Jürgen Unützer; Peter Ventevogel; Meenakshi Sharma; Graham Thornicroft; Shekhar Saxena

doi:10.1371/journal.pmed.1001122

Abstract

Funding for the mhGAP Programme, under which the work reported in this manuscript was done, was by the following: American Psychiatric Foundation, USA; Association of Aichi Psychiatric Hospitals, Japan; Speaks, USA; CBM; Government of Italy; Government of Japan; Government of The Netherlands; Bureau for Epilepsy; International League Against Epilepsy; Medical Research Council, UK; National of Mental Health, USA; Public Health Agency of Canada, Canada; Rockefeller Foundation, USA; Shirley , UK; Syngenta, Switzerland; United Nations Population Fund;World Psychiatric Association

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dua et al. (2011) studied this question.

synapsesocial.com/papers/699629727edf91e849623639 https://doi.org/10.1371/journal.pmed.1001122

View Full Paper

Ask AI

Bookmark

Share

Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations

Abstract

Discussion

Cite This Study

Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations

Abstract

Discussion

Cite This Study

Keep reading

Keep reading